Comprehensive Financial Consultants Institutional’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
MC
NAM
SFS
BPA
TRCT
Comprehensive Financial Consultants Institutional's SBIO Position: Q1 2022 in Review
Comprehensive Financial Consultants Institutional sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2022, closing a stake of 34 shares — an estimated $1K sold.
Comprehensive Financial Consultants Institutional first reported a position in SBIO in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 56 funds tracked by Wall St. Rank hold SBIO as of Q1 2022.
- Comprehensive Financial Consultants Institutional reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2022 after selling out during the quarter.
- Comprehensive Financial Consultants Institutional sold 34 ALPS Medical Breakthroughs ETF shares in Q1 2022, an estimated $1K.
- Comprehensive Financial Consultants Institutional first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and held it in 1 quarter.
- Comprehensive Financial Consultants Institutional's ALPS Medical Breakthroughs ETF position peaked at $1K in Q4 2021.
- 56 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2022.
Based on Comprehensive Financial Consultants Institutional's 13F filing for Q1 2022, filed 11 May 2022.